(MedPage Today) — The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first approved dual-agent eye drop therapy for age-related vision decline.
The eye drops contain two active…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119645
Author :
Publish date : 2026-01-29 18:30:00
Copyright for syndicated content belongs to the linked Source.
